 | • レポートコード：GIR-2104Z06230 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、フロセミドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。フロセミドの種類別市場規模（注射、溶液、錠剤）、用途別市場規模（病院、薬局、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・フロセミドの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Sanofi Aventis、US Pharm Holdings、Mylan、Sandoz、Hospira、West-Ward Pharms、Ivax Sub Teva Pharms、Emcure Pharms、Sun Pharm Inds ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：注射、溶液、錠剤 ・用途別分析2016年-2026年：病院、薬局、診療所、その他 ・フロセミドの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・フロセミドのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・フロセミドのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・フロセミドの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・フロセミドの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Furosemide market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Furosemide size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Furosemide market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Furosemide market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Injection
Solution
Tablet
Market segment by Application can be divided into
Hospital
Pharmacy
Clinics
Others
The key market players for global Furosemide market are listed below:
Sanofi Aventis
US Pharm Holdings
Mylan
Sandoz
Hospira
West-Ward Pharms
Ivax Sub Teva Pharms
Emcure Pharms
Sun Pharm Inds
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Furosemide Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Furosemide Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Injection
1.2.3 Solution
1.2.4 Tablet
1.3 Market Analysis by Application
1.3.1 Overview: Global Furosemide Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Clinics
1.3.5 Others
1.4 Global Furosemide Market Size & Forecast
1.4.1 Global Furosemide Sales in Value (2016-2026))
1.4.2 Global Furosemide Sales in Volume (2016-2026)
1.4.3 Global Furosemide Price by Type (2016-2026) & (USD/Kg)
1.5 Global Furosemide Production Capacity Analysis
1.5.1 Global Furosemide Total Production Capacity (2016-2026)
1.5.2 Global Furosemide Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Furosemide Market Drivers
1.6.2 Furosemide Market Restraints
1.6.3 Furosemide Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi Aventis
2.1.1 Sanofi Aventis Details
2.1.2 Sanofi Aventis Major Business
2.1.3 Sanofi Aventis Furosemide Product and Services
2.1.4 Sanofi Aventis Furosemide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 US Pharm Holdings
2.2.1 US Pharm Holdings Details
2.2.2 US Pharm Holdings Major Business
2.2.3 US Pharm Holdings Furosemide Product and Services
2.2.4 US Pharm Holdings Furosemide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Furosemide Product and Services
2.3.4 Mylan Furosemide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Sandoz
2.4.1 Sandoz Details
2.4.2 Sandoz Major Business
2.4.3 Sandoz Furosemide Product and Services
2.4.4 Sandoz Furosemide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Hospira
2.5.1 Hospira Details
2.5.2 Hospira Major Business
2.5.3 Hospira Furosemide Product and Services
2.5.4 Hospira Furosemide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 West-Ward Pharms
2.6.1 West-Ward Pharms Details
2.6.2 West-Ward Pharms Major Business
2.6.3 West-Ward Pharms Furosemide Product and Services
2.6.4 West-Ward Pharms Furosemide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Ivax Sub Teva Pharms
2.7.1 Ivax Sub Teva Pharms Details
2.7.2 Ivax Sub Teva Pharms Major Business
2.7.3 Ivax Sub Teva Pharms Furosemide Product and Services
2.7.4 Ivax Sub Teva Pharms Furosemide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Emcure Pharms
2.8.1 Emcure Pharms Details
2.8.2 Emcure Pharms Major Business
2.8.3 Emcure Pharms Furosemide Product and Services
2.8.4 Emcure Pharms Furosemide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Sun Pharm Inds
2.9.1 Sun Pharm Inds Details
2.9.2 Sun Pharm Inds Major Business
2.9.3 Sun Pharm Inds Furosemide Product and Services
2.9.4 Sun Pharm Inds Furosemide Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Furosemide Sales by Manufacturer
3.1 Global Furosemide Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Furosemide Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Furosemide
3.4 Market Concentration Rate
3.4.1 Top 3 Furosemide Manufacturer Market Share
3.4.2 Top 6 Furosemide Manufacturer Market Share
3.5 Global Furosemide Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Furosemide Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Furosemide Market Size by Region
4.1.1 Global Furosemide Sales in Volume by Region (2016-2026)
4.1.2 Global Furosemide Revenue by Region (2016-2026)
4.2 North America Furosemide Revenue (2016-2026)
4.3 Europe Furosemide Revenue (2016-2026)
4.4 Asia-Pacific Furosemide Revenue (2016-2026)
4.5 South America Furosemide Revenue (2016-2026)
4.6 Middle East and Africa Furosemide Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Furosemide Sales in Volume by Type (2016-2026)
5.2 Global Furosemide Revenue by Type (2016-2026)
5.3 Global Furosemide Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Furosemide Sales in Volume by Application (2016-2026)
6.2 Global Furosemide Revenue by Application (2016-2026)
6.3 Global Furosemide Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Furosemide Sales by Type (2016-2026)
7.2 North America Furosemide Sales by Application (2016-2026)
7.3 North America Furosemide Market Size by Country
7.3.1 North America Furosemide Sales in Volume by Country (2016-2026)
7.3.2 North America Furosemide Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Furosemide Sales by Type (2016-2026)
8.2 Europe Furosemide Sales by Application (2016-2026)
8.3 Europe Furosemide Market Size by Country
8.3.1 Europe Furosemide Sales in Volume by Country (2016-2026)
8.3.2 Europe Furosemide Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Furosemide Sales by Type (2016-2026)
9.2 Asia-Pacific Furosemide Sales by Application (2016-2026)
9.3 Asia-Pacific Furosemide Market Size by Region
9.3.1 Asia-Pacific Furosemide Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Furosemide Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Furosemide Sales by Type (2016-2026)
10.2 South America Furosemide Sales by Application (2016-2026)
10.3 South America Furosemide Market Size by Country
10.3.1 South America Furosemide Sales in Volume by Country (2016-2026)
10.3.2 South America Furosemide Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Furosemide Sales by Type (2016-2026)
11.2 Middle East & Africa Furosemide Sales by Application (2016-2026)
11.3 Middle East & Africa Furosemide Market Size by Country
11.3.1 Middle East & Africa Furosemide Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Furosemide Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Furosemide Typical Distributors
12.3 Furosemide Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Furosemide Revenue by Type, (USD Million), 2021-2026
Table 2. Global Furosemide Revenue by Application, (USD Million), 2021-2026
Table 3. Sanofi Aventis Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Aventis Major Business
Table 5. Sanofi Aventis Furosemide Product and Services
Table 6. Sanofi Aventis Furosemide Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. US Pharm Holdings Basic Information, Manufacturing Base and Competitors
Table 8. US Pharm Holdings Major Business
Table 9. US Pharm Holdings Furosemide Product and Services
Table 10. US Pharm Holdings Furosemide Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Mylan Basic Information, Manufacturing Base and Competitors
Table 12. Mylan Major Business
Table 13. Mylan Furosemide Product and Services
Table 14. Mylan Furosemide Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Sandoz Basic Information, Manufacturing Base and Competitors
Table 16. Sandoz Major Business
Table 17. Sandoz Furosemide Product and Services
Table 18. Sandoz Furosemide Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Hospira Basic Information, Manufacturing Base and Competitors
Table 20. Hospira Major Business
Table 21. Hospira Furosemide Product and Services
Table 22. Hospira Furosemide Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. West-Ward Pharms Basic Information, Manufacturing Base and Competitors
Table 24. West-Ward Pharms Major Business
Table 25. West-Ward Pharms Furosemide Product and Services
Table 26. West-Ward Pharms Furosemide Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Ivax Sub Teva Pharms Basic Information, Manufacturing Base and Competitors
Table 28. Ivax Sub Teva Pharms Major Business
Table 29. Ivax Sub Teva Pharms Furosemide Product and Services
Table 30. Ivax Sub Teva Pharms Furosemide Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Emcure Pharms Basic Information, Manufacturing Base and Competitors
Table 32. Emcure Pharms Major Business
Table 33. Emcure Pharms Furosemide Product and Services
Table 34. Emcure Pharms Furosemide Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Sun Pharm Inds Basic Information, Manufacturing Base and Competitors
Table 36. Sun Pharm Inds Major Business
Table 37. Sun Pharm Inds Furosemide Product and Services
Table 38. Sun Pharm Inds Furosemide Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Global Furosemide Sales by Manufacturer (2019-2021e) & (MT)
Table 40. Global Furosemide Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 41. Market Position of Manufacturers in Furosemide, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 42. Global Furosemide Production Capacity by Company, (MT): 2020 VS 2021
Table 43. Head Office and Furosemide Production Site of Key Manufacturer
Table 44. Global Furosemide Sales by Region (2016-2021e) & (MT)
Table 45. Global Furosemide Sales by Region (2021-2026) & (MT)
Table 46. Global Furosemide Revenue by Region (2016-2021e) & (USD Million)
Table 47. Global Furosemide Revenue by Region (2021-2026) & (USD Million)
Table 48. Global Furosemide Sales by Type (2016-2021e) & (MT)
Table 49. Global Furosemide Sales by Type (2021-2026) & (MT)
Table 50. Global Furosemide Revenue by Type (2016-2021e) & (USD Million)
Table 51. Global Furosemide Revenue by Type (2021-2026) & (USD Million)
Table 52. Global Furosemide Price by Type (2016-2021e) & (USD/Kg)
Table 53. Global Furosemide Price by Type (2021-2026) & (USD/Kg)
Table 54. Global Furosemide Sales by Application (2016-2021e) & (MT)
Table 55. Global Furosemide Sales by Application (2021-2026) & (MT)
Table 56. Global Furosemide Revenue by Application (2016-2021e) & (USD Million)
Table 57. Global Furosemide Revenue by Application (2021-2026) & (USD Million)
Table 58. Global Furosemide Price by Application (2016-2021e) & (USD/Kg)
Table 59. Global Furosemide Price by Application (2021-2026) & (USD/Kg)
Table 60. North America Furosemide Sales by Country (2016-2021e) & (MT)
Table 61. North America Furosemide Sales by Country (2021-2026) & (MT)
Table 62. North America Furosemide Revenue by Country (2016-2021e) & (USD Million)
Table 63. North America Furosemide Revenue by Country (2021-2026) & (USD Million)
Table 64. North America Furosemide Sales by Type (2016-2021e) & (MT)
Table 65. North America Furosemide Sales by Type (2021-2026) & (MT)
Table 66. North America Furosemide Sales by Application (2016-2021e) & (MT)
Table 67. North America Furosemide Sales by Application (2021-2026) & (MT)
Table 68. Europe Furosemide Sales by Country (2016-2021e) & (MT)
Table 69. Europe Furosemide Sales by Country (2021-2026) & (MT)
Table 70. Europe Furosemide Revenue by Country (2016-2021e) & (USD Million)
Table 71. Europe Furosemide Revenue by Country (2021-2026) & (USD Million)
Table 72. Europe Furosemide Sales by Type (2016-2021e) & (MT)
Table 73. Europe Furosemide Sales by Type (2021-2026) & (MT)
Table 74. Europe Furosemide Sales by Application (2016-2021e) & (MT)
Table 75. Europe Furosemide Sales by Application (2021-2026) & (MT)
Table 76. Asia-Pacific Furosemide Sales by Region (2016-2021e) & (MT)
Table 77. Asia-Pacific Furosemide Sales by Region (2021-2026) & (MT)
Table 78. Asia-Pacific Furosemide Revenue by Region (2016-2021e) & (USD Million)
Table 79. Asia-Pacific Furosemide Revenue by Region (2021-2026) & (USD Million)
Table 80. Asia-Pacific Furosemide Sales by Type (2016-2021e) & (MT)
Table 81. Asia-Pacific Furosemide Sales by Type (2021-2026) & (MT)
Table 82. Asia-Pacific Furosemide Sales by Application (2016-2021e) & (MT)
Table 83. Asia-Pacific Furosemide Sales by Application (2021-2026) & (MT)
Table 84. South America Furosemide Sales by Country (2016-2021e) & (MT)
Table 85. South America Furosemide Sales by Country (2021-2026) & (MT)
Table 86. South America Furosemide Revenue by Country (2016-2021e) & (USD Million)
Table 87. South America Furosemide Revenue by Country (2021-2026) & (USD Million)
Table 88. South America Furosemide Sales by Type (2016-2021e) & (MT)
Table 89. South America Furosemide Sales by Type (2021-2026) & (MT)
Table 90. South America Furosemide Sales by Application (2016-2021e) & (MT)
Table 91. South America Furosemide Sales by Application (2021-2026) & (MT)
Table 92. Middle East & Africa Furosemide Sales by Country (2016-2021e) & (MT)
Table 93. Middle East & Africa Furosemide Sales by Country (2021-2026) & (MT)
Table 94. Middle East & Africa Furosemide Revenue by Country (2016-2021e) & (USD Million)
Table 95. Middle East & Africa Furosemide Revenue by Country (2021-2026) & (USD Million)
Table 96. Middle East & Africa Furosemide Sales by Type (2016-2021e) & (MT)
Table 97. Middle East & Africa Furosemide Sales by Type (2021-2026) & (MT)
Table 98. Middle East & Africa Furosemide Sales by Application (2016-2021e) & (MT)
Table 99. Middle East & Africa Furosemide Sales by Application (2021-2026) & (MT)
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Furosemide Typical Distributors
Table 103. Furosemide Typical Customers
List of Figures
Figure 1. Furosemide Picture
Figure 2. Global Furosemide Sales Market Share by Type in 2020
Figure 3. Injection
Figure 4. Solution
Figure 5. Tablet
Figure 6. Global Furosemide Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Pharmacy
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Furosemide Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 12. Global Furosemide Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Furosemide Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Furosemide Sales (2016-2026) & (MT)
Figure 33. Global Furosemide Production Capacity (2016-2026) & (MT)
Figure 34. Global Furosemide Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Furosemide Market Drivers
Figure 36. Furosemide Market Restraints
Figure 37. Furosemide Market Trends
Figure 38. Global Furosemide Sales Market Share by Manufacturer in 2020
Figure 39. Global Furosemide Revenue Market Share by Manufacturer in 2020
Figure 40. Furosemide Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Furosemide Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Furosemide Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Furosemide Sales Market Share by Region (2016-2026)
Figure 44. Global Furosemide Revenue Market Share by Region (2016-2026)
Figure 45. North America Furosemide Revenue (2016-2026) & (USD Million)
Figure 46. Europe Furosemide Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Furosemide Revenue (2016-2026) & (USD Million)
Figure 48. South America Furosemide Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Furosemide Revenue (2016-2026) & (USD Million)
Figure 50. Global Furosemide Sales Market Share by Type (2016-2026)
Figure 51. Global Furosemide Revenue Market Share by Type (2016-2026)
Figure 52. Global Furosemide Price by Type (2016-2026) & (USD/Kg)
Figure 53. Global Furosemide Sales Market Share by Application (2016-2026)
Figure 54. Global Furosemide Revenue Market Share by Application (2016-2026)
Figure 55. Global Furosemide Price by Application (2016-2026) & (USD/Kg)
Figure 56. North America Furosemide Sales Market Share by Country (2016-2026)
Figure 57. North America Furosemide Revenue Market Share by Country (2016-2026)
Figure 58. North America Furosemide Sales Market Share by Type (2016-2026)
Figure 59. North America Furosemide Sales Market Share by Application (2016-2026)
Figure 60. Europe Furosemide Sales Market Share by Country (2016-2026)
Figure 61. Europe Furosemide Revenue Market Share by Country (2016-2026)
Figure 62. Europe Furosemide Sales Market Share by Type (2016-2026)
Figure 63. Europe Furosemide Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Furosemide Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Furosemide Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Furosemide Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Furosemide Sales Market Share by Application (2016-2026)
Figure 68. South America Furosemide Sales Market Share by Country (2016-2026)
Figure 69. South America Furosemide Revenue Market Share by Country (2016-2026)
Figure 70. South America Furosemide Sales Market Share by Type (2016-2026)
Figure 71. South America Furosemide Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Furosemide Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Furosemide Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Furosemide Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Furosemide Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の特発性頭蓋内圧亢進症治療市場規模・現状・予測（2021年-2027年） Idiopathic intracranial hypertension is characterized by a buildup of the cerebrospinal fluid causing increase in the blood volume in vessels surrounding the brain and increase in brain swelling. The increase in salt intake causes water retention in the body together with fat adding on to the calori…- 世界のビンクリスチン硫酸塩リポソーム注射市場 2021：企業別、地域別、種類・用途別 The Vincristine Sulfate Liposome Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 世界のビンクリスチン硫酸塩リポソーム注射薬市場 2021：企業別、地域別、種類・用途別 The Vincristine Sulfate Liposome Injection Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 世界の緩衝髄腔内電解質/デキストロース注射市場 2021：企業別、地域別、種類・用途別 The Buffered Intrathecal Electrolyte/Dextrose Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- 世界の調剤薬局市場規模・現状・予測（2021年-2027年） Compounding Pharmacy includes pharmaceutical ingredient alteration (PIA), pharmaceutical application alteration (PAA), currently unavailable pharmaceutical manufacturing (CUPM), pharmaceutical dosage alteration (PDA) and specialized animal pharmaceutical manufacturing (SAPM), the proportion of Pharm…